Cladribine is a cancer medication that interferes with the growth and spread of cancer cells in the body. Cladribine is used to treat hairy cell leukemia (a type of blood cancer). Cladribine may also be used for purposes not listed in this medication guide.
Cladribine is a synthetic anti-cancer drug used to suppress the immune system. Cladribine trades with the name litak, leustatin, or movectro. Cladribine is utilized in the treatment of hairy cell leukemia. Cladribine works by mimicking nucleoside adenosine which interferes with the processing of DNA. Cladribine can also be employed in the treatment of histiocytosis.